Business
TNI BioTech, Inc. Appoints Industry Veteran, Dr. Joseph Fortunak, as a Strategic Consultant
TNI BioTech, Inc. Appoints Industry Veteran, Dr. Joseph Fortunak, as a Strategic Consultant.
About this update from Biostax Corp.
[{"type":"text","content":"\n\n\n\n\n\n\n\nTNI BioTech, Inc. Appoints Industry Veteran, Dr. Joseph Fortunak, as a Strategic Consultant\n\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:\"0in\";\n}\n\n\n\n\n\n\n\n\n\n\nTNI BioTech, Inc. Appoints Industry Veteran, Dr. Joseph Fortunak, as a Strategic Consultant\n\nPR Newswire\n\nBETHESDA, Md., April 30, 2013\n\n\n\n\n\n\n\nBETHESDA, Md., April 30, 2013 /PRNewswire/ -- TNI BioTech, Inc. (OTC PINK: TNIB) announced today the appointment of industry veteran, Dr. Joseph M. Fortunak, as a strategic consultant to the company. Dr. Fortunak is the former director and head of Global Chemical Development at Abbott Laboratories Corporation, where he managed more than 350 scientists and technical experts.\n\n\nDr. Fortunak spent 10 years at SmithKline Beecham (now part of GlaxoSmithKline) working in process chemistry and drug development. Dr. Fortunak worked for 8 years at DuPont Pharmaceuticals, rising to the level of executive director of chemical development. From 2000-2004, Dr. Fortunak then served as the head of Global Chemical Development for Abbott Labs. While in the industry, Dr. Fortunak made significant contributions to 15 new chemical entities for the treatment of HIV/AIDS, malaria, cancer, and various cardiovascular and central nervous system (CNS) indications. He also contributed to roughly 20 new generic drug launches.\n\n\n\"Dr. Fortunak is a strong addition to our team,\" said Noreen Griffin, CEO and Director of TNI BioTech, Inc. Ms. Griffin continued, \"His influence in the pharmaceutical and healthcare sectors offers a tremendous resource to our organization as we focus on various products in development at TNIB. The timing is perfect as we begin to establish a team of well-respected authorities in the industry.\"\n\n\nIn 2004, Dr. Fortunak joined Howard University in Washington, D.C. with a joint appointment in chemistry and pharmaceutical sciences. Dr. Fortunak consults in various advisory capacities for non-governmental organizations, including the Clinton Foundation and the World Health Organization. He has worked with Indian drug companies on the approval ...